19 employees
Think Bioscience is reimagining synthetic biology by guiding the design and assembly of better medicines through the use of living systems.
2019
$17M
from 6 investors over 6 rounds
Think Bioscience raised $17M on August 18, 2022
Investors: LiquidMetal Ventures 观正资本, Wireframe Ventures, Xora Innovation, Innovation Endeavors, Buff Gold Ventures and AV8 Ventures